Ukusetyenziswa kwe-NSAID Ukufumana Ubuhlungu obungapheliyo

Ii-NSAID Zivame ukusetyenziswa ngokuPhepha koPhulo olungapheliyo

Ukuba ufunda ileyibhile yeenhlungu ezininzi zokunciphisa ubuhlungu, uya kubona ingcebiso malunga nokuqhagamshelana nodokotela wakho ukuba intlungu yakho ihlala ixesha elide kuneveki okanye njalo. Ewe, ukuba unentlungu engapheliyo, intlungu yakho mhlawumbi ihlale inyanga okanye ngaphezulu. Oku akuthethi ukuba izidakamizwa ezichasayo ezingabhubhisiyo (i-NSAID) azifanelekanga unyango olungapheliyo .

Enyanisweni, ii-NSAID zihlala zisetyenziselwa ukulawula ubuhlungu obungamaxesha obuhlungu kunye ne-arthritis. Zingathatyathwa ngaphezu kweminye imilenze enjengee- opioids okanye i- analgesics ene-adjuvant yokulawula intlungu .

Uninzi lwe-NSAID lufumaneka kwi-over-counter-counter-counter, nakuba iifom ezinamandla zingadinga isigqirha segqirha. Ezinye i-NSAID zifumaneka kuphela kumandla omyalelo. Ezi zizona zi-NSAID eziqhelekileyo ezisetyenziselwa ubuhlungu obungapheliyo.

I-NSAID ze-Over-Counter Counter Pain

I-NSAID ye-Prescription ye-Pain Chronicle

Ukhuselo lwe-NSAID kunye nobuhlungu obungapheliyo

Zonke i-NSAID zeentlungu ezingapheliyo, kubandakanywa nabo bathengiweyo kwi-counter-counter, ngoku zibandakanya izixwayiso ze-FDA zeengxaki zabo. Nangona kunjalo, baqhubeka beyodwa yeeklasi ezidume kakhulu zezidakamizwa ezisetyenziselwa ukunyanga intlungu.

I-NSAID yesigqirha yentlungu engapheliyo inokucetyiswa ukuba isebenzise ixesha elide ukuba umntu unomngcipheko ophezulu weengxaki ze-GI. Aba bantu bangabandakanya abantu abadala kunye nabani na abaneembali zezilonda okanye ezinye iingxaki eziphazamisayo.

Ukuba uthatha ii-NSAID zintlungu engapheliyo, ungamangaliswa ukuba ugqirha wakho uhlola rhoqo igazi lakho. Ubunokuthi unobungozi be-NSAID bunokuphetshwa ngokubeka esweni kokubala kwegazi lakho kunye namanqanaba akho okudala. Ukuba amazinga akho akonakala, uogqirha wakho unokutshintsha amayeza akho okanye anikezele amanye amachiza ukuba aphikiselele naziphi na iingxaki.

Imithombo:

I-American Chronic Pain Association. I-APCA Imithi kunye nobuhlungu obungapheliyo: I-Supplement 2007. Kufumaneka ngomhla we-6/21/09. http://www.theacpa.org/documents/ACPA%20Meds%202007%20Final.pdf

I-Merck Manuals iTree Library yeLayibrari. Ubuhlungu: unyango. Fi kelelwa ngo 6/21/09. http://www.merck.com/mmhe/sec06/ch078/ch078d.html

I-Patino FG, u-Olivieri J, u-Allison JJ, u-Mikuls TR, u-Moreland L, uKovac SH, u-Juarez L, Umntu S, uC Curtis J, noSaag KG. I-Nonsteroidal Antiinflammatory Monitoring and Disease Practices. Journal of Rheumatology. NgoDisemba ka-2003; 30 (12): 2680-8

I-US Food and Drug Administration. I-COX-2 ekhethiweyo (iquka i-Bextra, i-Celebrex, kunye ne-Vioxx) kunye ne-Non-Steroidal Anti-Inflammatory drugs (I-NSAIDs). Fi kelelwa ngo 6/21/09. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm